Literature DB >> 8445328

Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells.

J Stadler1, B G Harbrecht, M Di Silvio, R D Curran, M L Jordan, R L Simmons, T R Billiar.   

Abstract

Macrophage production of nitric oxide (.N = O) leads to considerable alterations of vital metabolic pathways in various target cells. The present study tested whether .N = O synthesis by Kupffer cells (KCs), the resident macrophages of the liver, interferes with the secretory function of these cells. As in other macrophage-type cells, the combination of lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) was a potent stimulus of .N = O synthesis by KC. Treatment with LPS and IFN-gamma also induced significant production of prostaglandin E2 (PGE2), thromboxane B2 (TBX2), tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6. Inhibition of .N = O synthesis by KC. Treatment with LPS and IFN-gamma also induced significant production of prostaglandin E2 (PGE2), thromboxane B2 (TBX2), tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6. Inhibition of .N = O synthesis by the L-arginine analogue of NG-monomethyl-L-arginine (NMA) resulted in a further increase of PGE2, TXB2, and IL-6 but not IL-1 and TNF-alpha production, indicating specific inhibitory effects of endogenous .N = O synthesis on the secretory activity of KCs. PGE2 production was most sensitive to the suppressive effect of .N = O and increased 24 h after stimulation with LPS and IFN-gamma from 16.3 +/- 4.9 ng/10(6) KCs without NMA to 94.3 +/- 17.9 ng/10(6) KCs with NMA. This effect of NMA was reversed by a 10-fold increase of the L-arginine concentration. No recovery of PGE2 production was seen when .N = O synthesis was blocked after 24 h. NMA treatment increased cyclooxygenase activity more than threefold, suggesting that .N = O inhibits PGE2 and TXB2 production through diminished PGH2 availability. .N = O synthesis did not significantly affect total protein synthesis or viability of the KCs. These results show that .N = O influences the production of specific inflammatory mediators by KCs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445328     DOI: 10.1002/jlb.53.2.165

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  39 in total

1.  Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?

Authors:  Mariza Bortolanza; Fernando E Padovan-Neto; Roberta Cavalcanti-Kiwiatkoski; Maurício Dos Santos-Pereira; Miso Mitkovski; Rita Raisman-Vozari; Elaine Del-Bel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 2.  The role of nitric oxide in prostaglandin biology; update.

Authors:  Sangwon F Kim
Journal:  Nitric Oxide       Date:  2011-07-26       Impact factor: 4.427

3.  Eicosanoids and nitric oxide influence induction of reactive gliosis from spreading depression in microglia but not astrocytes.

Authors:  A O Caggiano; R P Kraig
Journal:  J Comp Neurol       Date:  1996-05-20       Impact factor: 3.215

4.  Induction of iNOS in a rat model of acute colitis.

Authors:  E Kankuri; M Z Asmawi; R Korpela; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

Review 5.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

Review 6.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

7.  Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Authors:  T A Swierkosz; J A Mitchell; T D Warner; R M Botting; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning.

Authors:  Yu-Ting Xuan; Yiru Guo; Yanqing Zhu; Hui Han; Robert Langenbach; Buddhadeb Dawn; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

9.  Inhibition of cytochromes P4501A by nitric oxide.

Authors:  J Stadler; J Trockfeld; W A Schmalix; T Brill; J R Siewert; H Greim; J Doehmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8).

Authors:  M Yoshida; M Kikukawa; H Hisa; S Satoh
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.